VivoSeq
Other

Perioperative Period

0

Pipeline Programs

3

Active Trials

0

Companies Involved

Perioperative Period is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

67/100

Attrition Rate

23/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

13

clinical trials

Completed6 · 46%
Not yet recruiting3 · 23%
Terminated3 · 23%
Unknown status1 · 8%

Trial Activity

13 trials

SGLT2 Inhibitors and Perioperative Period
Not yet recruiting··N/A·NCT06326528·100 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)